post treatment test by Veridex, LLC?
Options
bdhilton
Member Posts: 852 Member
Anyone familar with this post treatment test by Veridex, LLC? They are an organization providing physicians with vitro diagnostic oncology products. Veridex's products may significantly benefit patients through earlier disease detection and may enable personalized strategies to help improve patient management and outcomes.
Why you need to be monitored
Once you are diagnosed with metastatic prostate cancer (MPC) and have begun therapy, it is important for the doctor to regularly assess your prognosis. By monitoring you throughout your treatment, your doctor can make more-informed decisions about your care.
Traditional methods of monitoring MPC include:
•physical exams
•Prostate specific antigen (PSA) testing
•bone scans
Another, newer method for monitoring MPC is the CellSearch® Circulating Tumor Cell (CTC) Test. Unlike other methods of monitoring MPC, the CTC test counts the number of cancer cells that have broken away from the tumor and are currently circulating in the blood stream. Clinical studies have shown that detection of these cells can predict disease progression and survival in patients with MPC.
A CTC test can be performed prior to beginning therapy, and then as early as 2-5 weeks after therapy initiation. In addition, CTC testing can be used at any time along the continuum of your care. This flexibility allows doctors to make informed patient care decisions earlier
http://www.veridex.com/
Why you need to be monitored
Once you are diagnosed with metastatic prostate cancer (MPC) and have begun therapy, it is important for the doctor to regularly assess your prognosis. By monitoring you throughout your treatment, your doctor can make more-informed decisions about your care.
Traditional methods of monitoring MPC include:
•physical exams
•Prostate specific antigen (PSA) testing
•bone scans
Another, newer method for monitoring MPC is the CellSearch® Circulating Tumor Cell (CTC) Test. Unlike other methods of monitoring MPC, the CTC test counts the number of cancer cells that have broken away from the tumor and are currently circulating in the blood stream. Clinical studies have shown that detection of these cells can predict disease progression and survival in patients with MPC.
A CTC test can be performed prior to beginning therapy, and then as early as 2-5 weeks after therapy initiation. In addition, CTC testing can be used at any time along the continuum of your care. This flexibility allows doctors to make informed patient care decisions earlier
http://www.veridex.com/
0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.2K Cancer specific
- 2.8K Anal Cancer
- 440 Bladder Cancer
- 306 Bone Cancers
- 1.6K Brain Cancer
- 28.4K Breast Cancer
- 391 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 12.9K Head and Neck Cancer
- 6.3K Kidney Cancer
- 666 Leukemia
- 789 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 235 Multiple Myeloma
- 7.1K Ovarian Cancer
- 53 Pancreatic Cancer
- 486 Peritoneal Cancer
- 5.3K Prostate Cancer
- 1.2K Rare and Other Cancers
- 532 Sarcoma
- 717 Skin Cancer
- 647 Stomach Cancer
- 190 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards